STAR Therapeutics
Health Care · Biotechnology

STAR Therapeutics news and milestones

STAR Therapeutics: 19 headlines on record, 1 headline in the last 90 days. Its story counts 3 milestones.

Data updated Nov 18, 2026 · Back to the company report
19Headlines
1In 90 days
3Milestones

Headlines

Oct 232026
News · Pulse 2.0
Star Therapeutics has raised $200 million in private financing to advance its next generation of therapeutic programs, move current preclinical assets into clinical development,…
Jun 262026
News · YahooFinance
SOUTH SAN FRANCISCO, Calif., June 26, 2026--Star Therapeutics, a late clinical-stage biotechnology company focused on the discovery and development of life-changing therapies for…
Jun 82026
Blog
Adam Rosenthal is the CEO and founder of Star Therapeutics, a biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible. The c…
Jun 82026
News · Star Tribune
Your source for Minnesota news today. Read articles, view photos or watch videos about news in Minneapolis, St. Paul, Duluth, St. Cloud, Rochester, and beyond.
Apr 212026
Blog
VGA039 is a once monthly, subcutaneously self-administered investigational therapy for the treatment of bleeding disorders, initially being evaluated for von Willebrand disease (…
Jan 52026
Blog
SOUTH SAN FRANCISCO, CA, January 5, 2026 - Star Therapeutics, a late clinical-stage biotechnology company discovering and developing best-in-class antibodies for bleeding disorde…
Dec 8, 20252025
Blog
Adam Rosenthal is the CEO and founder of Star Therapeutics, a biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible. The c…
Dec 7, 20252025
Blog
Adam Rosenthal is the CEO and founder of Star Therapeutics, a biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible. The c…
Dec 7, 20252025
Blog
VGA039 is a once monthly, subcutaneously self-administered therapy for the treatment of bleeding disorders, starting with von Willebrand disease (VWD)Multidose data demonstrate s…
Dec 6, 20252025
Blog
Adam Rosenthal is the CEO and founder of Star Therapeutics, a biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible. The c…
Oct 12, 20252025
News · Pulse 2.0
Star Therapeutics, an innovative clinical-stage biotechnology company, is dedicated to discovering and developing cutting-edge antibodies aimed at treating bleeding disorders and…
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

STAR Therapeutics, News. Alion, Nov 18, 2026. https://alion.io/company/world-3783084/news

.json · .md · CC BY-SA 4.0